Skip to main content
Watch Insiders

Corporate insider profile

Douglas Kerr Insider Trades

Latest reported as Chief Medical Officer of Dyne Therapeutics, Inc. (DYN).

Purchase filings
0
Reported companies
1
Net open-market value
-$201,411.63
Latest transaction
Sep 8, 2026

Affiliated corporations

Reported company relationships

DYNLatest reported

Dyne Therapeutics, Inc.

Chief Medical Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 8, 2026Dyne Therapeutics, Inc. (DYN)Chief Medical OfficerSale5,035$22.95$115,546
Aug 13, 2026Dyne Therapeutics, Inc. (DYN)Chief Medical OfficerSale1,556$26.28$40,892
Jun 16, 2026Dyne Therapeutics, Inc. (DYN)Chief Medical OfficerSale887$18.33$16,259
May 13, 2026Dyne Therapeutics, Inc. (DYN)Chief Medical OfficerSale1,564$18.36$28,715